The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein a-I and malondialdehyde in type 2 diabetic patients
- PMID: 25561919
- PMCID: PMC4277626
The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein a-I and malondialdehyde in type 2 diabetic patients
Abstract
Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Anti-diabetic, hypolipidemic and anti-oxidative properties of ginger have been noticed in several researches. The present study was conducted to investigate the effects of ginger on fasting blood sugar, Hemoglobin A1c, apolipoprotein B, apolipoprotein A-I, and malondialdehyde in type 2 diabetic patients. In a randomized, double-blind, placebo-controlled, clinical trial, a total of 41 type 2 diabetic patients randomly were assigned to ginger or placebo groups (22 in ginger group and 19 in control group), received 2 g/day of ginger powder supplement or lactose as placebo for 12 weeks. The serum concentrations of fasting blood sugar, Hemoglobin A1c, apolipoprotein B, apolipoprotein A-I and malondialdehyde were analyzed before and after the intervention. Ginger supplementation significantly reduced the levels of fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein B/apolipoprotein A-I and malondialdehyde in ginger group in comparison to baseline, as well as control group, while it increased the level of apolipoprotein A-I (p<0.05). It seems that oral administration of ginger powder supplement can improves fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein A-I, apolipoprotein B/apolipoprotein A-I and malondialdehyde in type 2 diabetic patients. So it may have a role in alleviating the risk of some chronic complications of diabetes.
Keywords: Apolipoproteins; Diabetes mellitus; Ginger; Glycemic status; Malondialdehyde.
Figures
Similar articles
-
The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, and Lipid Profiles in Patients with Type 2 Diabetes.Int J Endocrinol Metab. 2017 Aug 27;15(4):e57927. doi: 10.5812/ijem.57927. eCollection 2017 Oct. Int J Endocrinol Metab. 2017. PMID: 29344037 Free PMC article.
-
The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Complement Ther Med. 2014 Feb;22(1):9-16. doi: 10.1016/j.ctim.2013.12.017. Epub 2014 Jan 8. Complement Ther Med. 2014. PMID: 24559810 Clinical Trial.
-
The effect of an oral ginger supplementation on NF-κB concentration in peripheral blood mononuclear cells and anthropomorphic data of patients with type 2 diabetes: A randomized double-blind, placebo-controlled clinical trial.Complement Ther Med. 2019 Feb;42:7-11. doi: 10.1016/j.ctim.2018.10.019. Epub 2018 Oct 26. Complement Ther Med. 2019. PMID: 30670285
-
Anti-inflammatory effects of zingiber officinale in type 2 diabetic patients.Adv Pharm Bull. 2013;3(2):273-6. doi: 10.5681/apb.2013.044. Epub 2013 Aug 20. Adv Pharm Bull. 2013. PMID: 24312847 Free PMC article.
-
The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus.Int J Food Sci Nutr. 2014 Jun;65(4):515-20. doi: 10.3109/09637486.2014.880671. Epub 2014 Feb 4. Int J Food Sci Nutr. 2014. PMID: 24490949 Clinical Trial.
Cited by 13 articles
-
Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.Clin Exp Gastroenterol. 2020 Jan 23;13:35-45. doi: 10.2147/CEG.S234698. eCollection 2020. Clin Exp Gastroenterol. 2020. PMID: 32158249 Free PMC article.
-
Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials.Nutrients. 2020 Jan 6;12(1):157. doi: 10.3390/nu12010157. Nutrients. 2020. PMID: 31935866 Free PMC article. Review.
-
Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters.Medicina (Kaunas). 2019 Sep 9;55(9):579. doi: 10.3390/medicina55090579. Medicina (Kaunas). 2019. PMID: 31505863 Free PMC article.
-
In Vitro Antioxidant and In Vivo Lipid-Lowering Properties of Zingiber officinale Crude Aqueous Extract and Methanolic Fraction: A Follow-Up Study.Evid Based Complement Alternat Med. 2019 Jul 9;2019:9734390. doi: 10.1155/2019/9734390. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31360211 Free PMC article.
-
Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.Daru. 2019 Dec;27(2):781-798. doi: 10.1007/s40199-019-00289-w. Epub 2019 Jul 27. Daru. 2019. PMID: 31352568 Free PMC article. Review.
References
-
- Li Y, Tran VH, Duke CC, Roufogalis BD. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta. Medica. 2012;78:1549–1555. - PubMed
-
- Elshater A-EA, Muhammad MA Salman, Mahrous MA Moussa. Effect of ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in Alloxan induced-diabetic rats. Egypt. Acad. J. Biology. Sci. 2009;2:153–162.
-
- Shanmugam K R, Ramakrishana Ch, Mallikarjuna K, Sathyavelu Reddy K. The impact of ginger on kidney carbohydrate metabolic profiles in STZ induced diabetic rats. . Asian. J. Exp. Sci. 2009;23:127–134.
-
- Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran. Diabetes Care . 2008;31:96–98. - PubMed
-
- Madkor HR, Mansour SW, Ramadan G. Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycemia, dyslipidemia and oxidative stress in streptozotocin-nicotinamide diabetic rats. Br. J. Nutr. 2011;105:1210–1217. - PubMed
LinkOut - more resources
-
Full Text Sources